U.S. Department of Health and Human Services
Teresa Jones

 Contact Info

Tel: 301-435-2996
Email: teresa.jones@nih.gov

 Select Experience

  • InvestigatorIntramural Research Program, NIDDK, NIH1995-2003
  • Fellowship - Board Certified in Endocrinology and MetabolismNIH1987-1989
  • Residency - Board Certified in Internal MedicineUniversity of Minnesota1983-1986
  • M.D.Northwestern University Honors Program in Medical Education1983

Current Responsibilities & Activities

Research on the diabetic complications of the lower extremity is my primary responsibility.  This research includes basic, translational, and clinical research to improve the understanding and treatment of diabetic neuropathy and diabetic wound healing.  I am the project scientist for the new Diabetic Foot Consortium that will develop biomarkers for diabetic foot ulcers.    

My program in diabetes complications also includes research on acute diabetes complications, such as diabetic ketoacidosis; research on the molecular and cellular impact of hyperglycemia and the other metabolic changes of diabetes that underlie tissue damage in multiple organ systems; and clinical research with outcome measures for multiple diabetic complications.  

I also serve as the program officer for the Preventing Early Renal Loss in Type 1 Diabetes (PERL) trial; the NIDDK project scientist and Physiology Committee Chair for the Trial to Assess Chelation Therapy 2 (TACT2) trial; and the program director for SBIR/STTR research on diabetes complications in the division of DEM.

​Research Programs

Bioengineering, Biotechnology, and Imaging as applied to Diabetes, Metabolic, and Endocrine Diseases
This program supports research that is aimed at applying sophisticated, cutting-edge technologies to advance the understanding of the mechanisms that underlie diabetes and other endocrine and metabolic diseases

Diabetes: Treatment, Prevention, and Complications
This program supports both basic and clinical studies aimed at addressing the prevention, treatment, and pathophysiology of type 1 and type 2 diabetes

Current Committee Memberships

  • Trans-NIH Medical Rehabilitation Coordinating Committee NIDDK Representative
  • Trans-NIH Diabetes Lower Extremity Complications Working GroupChair
  • Metabolic Disorders Steering Committee of the Biomarkers Consortium of the Foundation for NIHMember